Aprile Francesco A, Arosio Paolo, Fusco Giuliana, Chen Serene W, Kumita Janet R, Dhulesia Anne, Tortora Paolo, Knowles Tuomas P J, Vendruscolo Michele, Dobson Christopher M, Cremades Nunilo
Department of Chemistry, University of Cambridge , Lensfield Road, Cambridge CB2 1EW, United Kingdom.
Department of Chemistry and Applied Biosciences, ETH Zurich , Vladimir-Prelog-Weg 1, 8093 Zurich, Switzerland.
Biochemistry. 2017 Mar 7;56(9):1177-1180. doi: 10.1021/acs.biochem.6b01178. Epub 2017 Feb 23.
The Hsp70 family of chaperones plays an essential role in suppressing protein aggregation in the cell. Here we investigate the factors controlling the intrinsic ability of human Hsp70 to inhibit the elongation of amyloid fibrils formed by the Parkinson's disease-related protein α-synuclein. Using kinetic analysis, we show that Hsp70 binds preferentially to α-synuclein fibrils as a consequence of variations in the association and dissociation rate constants of binding to the different aggregated states of the protein. Our findings illustrate the importance of the kinetics of binding of molecular chaperones, and also of potential therapeutic molecules, in the efficient suppression of specific pathogenic events linked to neurodegeneration.
伴侣蛋白Hsp70家族在抑制细胞内蛋白质聚集方面发挥着至关重要的作用。在此,我们研究了控制人类Hsp70抑制帕金森病相关蛋白α-突触核蛋白形成淀粉样纤维伸长的内在能力的因素。通过动力学分析,我们发现Hsp70优先结合α-突触核蛋白纤维,这是由于其与该蛋白不同聚集状态结合的缔合和解离速率常数存在差异。我们的研究结果说明了分子伴侣以及潜在治疗分子的结合动力学在有效抑制与神经退行性变相关的特定致病事件中的重要性。